LUTATHERA Injection General Use Result Survey

Clinical trial NCT05844332 · COMPLETED

Trial details

NCT number: NCT05844332
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Somatostatin Receptor-positive Neuroendocrine Tumor

Start date: 2021-12-17
Primary completion: 2024-06-27
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.